COVID-19 in people living with HIV: A multicenter case-series study

Alfonso Cabello1, Belén Zamarro1, Sara Nistal2

  • 1Division of Infectious Diseases, Fundación Jiménez Díaz University Hospital, Research Health Institute, Autónoma de Madrid University (IIS-FJD, UAM), Spain.

Insights

COVID-19 outcomes in people living with HIV (PLHIV) are primarily determined by age and comorbidities, not HIV severity or antiretroviral therapy. PLHIV experienced similar hospitalization and ICU admission rates but lower mortality compared to those without HIV.

Area of Science:

  • Infectious Diseases
  • Virology
  • Public Health

Background:

  • Limited data exists on the impact of COVID-19 on individuals living with HIV (PLHIV).
  • Understanding COVID-19's effects on PLHIV is crucial for public health strategies and clinical management.

Purpose of the Study:

  • To investigate the clinical presentation, severity, and outcomes of COVID-19 in people living with HIV.
  • To compare COVID-19 outcomes between PLHIV and individuals without HIV.

Main Methods:

  • An observational study was conducted in four Madrid hospitals.
  • Included were HIV patients with confirmed or suspected COVID-19, compared to non-HIV COVID-19 patients.
  • Data collected included demographics, comorbidities, symptoms, disease severity, hospitalization, ICU admission, and mortality.

Main Results:

  • Sixty-three PLHIV with COVID-19 were analyzed; 84.1% had comorbidities. Common symptoms included fever, cough, and dyspnea.
  • Pneumonia occurred in 47.5%, severe disease in 28.6%, and hospitalization in 32.3%. ICU admission and mortality rates were 3.17%.
  • Age, hypertension, overweight, and diabetes were associated with COVID-19 severity. HIV-related factors did not influence outcomes. Hospitalization and ICU rates were similar to non-HIV patients, with lower mortality in PLHIV.

Conclusions:

  • Established COVID-19 prognostic factors like age and comorbidities are key determinants for PLHIV.
  • HIV severity and antiretroviral therapy type did not appear to affect COVID-19 outcomes.
  • Further large prospective studies are needed to fully elucidate differences between HIV-positive and HIV-negative patients.
Abstract

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
652
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.7K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.6K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
66
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
571
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K